Orion and Criceto Announce a License Agreement for APORON®, an Innovative Apomorphine Spray to Treat OFF Episodes in Parkinson’s Disease Orion Corporation (“Orion”) and Criceto IKM B.V ...

Apr. 9, 2025 — A small protein involved in neurodegeneration leading to Parkinson's disease also drives a type of skin cancer known as melanoma, according to new ... Apr. 7, 2025 — A study ...

These mysterious droplets, known ... AI Tool to Better Assess Parkinson's Disease, Other Movement Disorders Apr. 14, 2025 — A groundbreaking open-source computer program uses artificial ...

Orion and Criceto Announce a License Agreement for APORON®, an Innovative Apomorphine Spray to Treat OFF Episodes in Parkinson’s Disease Orion Corporation (“Orion”) and Criceto IKM B.V. (“Criceto”) ...

A selection of highlights from Sir Peter Ustinov's appearances on Parkinson. A look back at a multitalented writer, director, actor and ambassador for Unicef.

A University of Florida researcher has developed an open-source computer program that uses artificial intelligence to analyze videos of patients with Parkinson's disease and other movement disorders.

Wrexham sit in second place in League One with two games left in the season and are on the hunt for promotion to the ...

Brought into the limelight by actor Michael J. Fox, Parkinson's disease affects the body's ability to control movement. The most prominent signs of Parkinson's disease result from damage to brain ...

A new AI tool called RibbonFold is revolutionizing how scientists understand misfolded proteins linked to Alzheimer’s and Parkinson’s. Unlike existing tools such as AlphaFold, which predict correctly ...

Look back at this selection of iconic Parkinson interviews from the 1970s and 1980s. Watch all your favourite ABC programs on ABC iview. More from ABC We acknowledge Aboriginal and Torres Strait ...

Denmark’s Lundbeck is bringing a third potential drug for Parkinson’s disease to the ... carbidopa and are experiencing “off” episodes, following a five-year battle with the regulator.